Recipharm and LIDDS establish industrial manufacturing capabilities for a novel prostate cancer product
Recipharm, the contract development and manufacturing organisation (CDMO), and LIDDS have together set up a...
Asia Precision Medicine Research Array For Regional Screening Initiatives Announced By Thermo Fisher Scientific
Epidemiologists conducting national precision medicine initiatives focused on gathering clinical research data on genetic variation...
Abbvie and principia announce collaboration on oral immunoproteasome inhibitors
AbbVie , a global biopharmaceutical company, and Principia Biopharma Inc., a private, clinical-stage biopharmaceutical company,...
Thermo Fisher Scientific and SRI International Collaborate to Enhance Small Molecule Research
Thermo Fisher Scientific Inc., the world leader in serving science, and SRI International, a research...
eTheRNA advances in-vivo mRNA cancer immunotherapy into first oncology clinical studies
eTheRNA immunotherapies, a clinical-stage company developing mRNA based cancer immunotherapies from its unique TriMix platform,...
Eisai Temporarily Withdraws New Drug Application for Anticancer Agent Halaven in China
Eisai Co., Ltd. announced today that, in alignment with Chinese regulations, it has temporarily withdrawn...
Sandoz receives approval in Europe for Rixathon® to treat blood cancers and immunological diseases
Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, announced today that...
Numerate and Takeda Enter Agreement to Generate Novel Clinical Candidates Using AI-Driven Drug Discovery
Numerate, Inc., a computational drug design company applying artificial intelligence (AI) at cloud scale to...
Eisai Enters Into Joint Research Agreement With The Broad Institute To Develop An Antimalarial...
Eisai Co Ltd announced that it has entered into a new joint research agreement with...
OBI Pharma to develop OBI-3424 (previously TH-3424) as a potential treatment of cancers expressing...
OBI Pharma, Inc., a Taiwan biopharma company announced an agreement with Threshold Pharmaceuticals, Inc. to...
